The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 28, 2023

Filed:

Mar. 29, 2019
Applicant:

Eureka Therapeutics, Inc., Emeryville, CA (US);

Inventors:

Jun Cui, Emeryville, CA (US);

Pengbo Zhang, Emeryville, CA (US);

Yiyang Xu, Emeryville, CA (US);

Shan Li, Emeryville, CA (US);

Yixiang Xu, Emeryville, CA (US);

Guangyan Xiong, Emeryville, CA (US);

Hongruo Yun, Emeryville, CA (US);

Lianxing Liu, Emeryville, CA (US);

Xiaomei Ge, Emeryville, CA (US);

Shaohua Xu, Emeryville, CA (US);

Hong Liu, Emeryville, CA (US);

Javier Morales, Emeryville, CA (US);

Assignee:

Eureka Therapeutics, Inc., Emeryville, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61P 35/00 (2006.01); C07K 14/725 (2006.01); A61K 39/00 (2006.01); G01N 33/574 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2803 (2013.01); A61P 35/00 (2018.01); C07K 14/7051 (2013.01); C07K 16/2809 (2013.01); G01N 33/57492 (2013.01); A61K 2039/505 (2013.01); C07K 2317/31 (2013.01); C07K 2317/622 (2013.01); C07K 2319/02 (2013.01); C07K 2319/03 (2013.01); G01N 2333/70503 (2013.01);
Abstract

Described herein are antibodies (e.g., single chain variable fragment (scFv) antibodies) and constructs comprising antibody moieties that bind to the extracellular domain of CD22 or a portion thereof (e.g., SEQ ID NO: 205 or a portion thereof). Also provided herein are methods of using the same or compositions thereof for the therapeutic treatment of diseases characterized by CD22 expression, in particular, B-cell lymphomas and leukemias.


Find Patent Forward Citations

Loading…